Trial Clinic For Psychedelics To Open In London| MENAFN.COM

Sunday, 02 October 2022 03:08 GMT

Trial Clinic For Psychedelics To Open In London


(MENAFN- Investor Brand Network)

After decades of prohibition and criminalization, various jurisdictions around the world have begun to loosen their restrictive psychedelic policies in what has been dubbed the psychedelics renaissance. There has been a significant surge in psychedelic interest among the scientific community, with researchers running several studies to look into the potential benefits and risks of using hallucinogenic drugs medicinally. Research has already shown that psychedelics have plenty of promise as treatments for mental-health conditions such as PTSD , depression and eating disorders , especially when paired with psychotherapy.

Researchers in London have been conducting clinical trials to test the potential of psychedelics as treatment for…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) are available in the company's newsroom at 

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text“Groovy” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit 

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: 

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California

415.949.5050 Office

PsychedelicNewsWire is part of the InvestorBrandNetwork .

MENAFN22092022000224011066ID1104909810


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.